In an era of increasingly bespoke healthcare, Elizabeth Philp has emerged as a formidable figure of innovation, especially in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a movement to make custom medications more obtainable, challenging the standard one-size-fit